advertisement

Topcon

Sun X 29

Showing records 1 to 25 | Display all abstracts from Sun X

117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Li S
eLife 2024; 12:
118713 Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Feng C
Frontiers in medicine 2024; 11: 1188193
118585 Iris Cerclage To Treat Persistent Mydriasis Following Acute Angle Closure Glaucoma Improves Visual Quality
Wang X
Journal of Glaucoma 2024; 33: 703-708
117559 Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery
Niu L
Journal of Ophthalmic Inflammation and Infection 2024; 14: 11
117409 Primary congenital glaucoma: We are always on the way
Yang H
Taiwan journal of ophthalmology 2024; 14: 190-196
118585 Iris Cerclage To Treat Persistent Mydriasis Following Acute Angle Closure Glaucoma Improves Visual Quality
Li T
Journal of Glaucoma 2024; 33: 703-708
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Ren J
eLife 2024; 12:
118713 Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Chen Q
Frontiers in medicine 2024; 11: 1188193
117409 Primary congenital glaucoma: We are always on the way
Lu W
Taiwan journal of ophthalmology 2024; 14: 190-196
117559 Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery
Luo Y; Xu H
Journal of Ophthalmic Inflammation and Infection 2024; 14: 11
117409 Primary congenital glaucoma: We are always on the way
Sun X
Taiwan journal of ophthalmology 2024; 14: 190-196
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Jiang Z
eLife 2024; 12:
118585 Iris Cerclage To Treat Persistent Mydriasis Following Acute Angle Closure Glaucoma Improves Visual Quality
Guo X
Journal of Glaucoma 2024; 33: 703-708
118713 Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Luan X; Luan X; Sun P
Frontiers in medicine 2024; 11: 1188193
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Qiu Y
eLife 2024; 12:
117559 Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery
Huang H
Journal of Ophthalmic Inflammation and Infection 2024; 14: 11
118585 Iris Cerclage To Treat Persistent Mydriasis Following Acute Angle Closure Glaucoma Improves Visual Quality
Feng Q
Journal of Glaucoma 2024; 33: 703-708
117559 Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery
Jiang R
Journal of Ophthalmic Inflammation and Infection 2024; 14: 11
118585 Iris Cerclage To Treat Persistent Mydriasis Following Acute Angle Closure Glaucoma Improves Visual Quality
Sun X
Journal of Glaucoma 2024; 33: 703-708
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Shao M
eLife 2024; 12:
118713 Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Cao Y; Wu J
Frontiers in medicine 2024; 11: 1188193
117559 Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery
Sun X
Journal of Ophthalmic Inflammation and Infection 2024; 14: 11
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Li Y
eLife 2024; 12:
118713 Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series
Wang S
Frontiers in medicine 2024; 11: 1188193
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Wu J; Song Y
eLife 2024; 12:

Issue 24-4

Change Issue


advertisement

Nidek